Cye
Last updated: Jul 31, 2026
Cye provides an AI-native continuous exposure-management platform that maps attack paths, quantifies cyber risk in financial terms, and prioritizes mitigation for enterprise security teams. Its software is paired with cybersecurity expertise and services for organizations that need to connect technical exposure with business or operational impact.
Visit WebsiteCompany Overview
Cye's core product is a continuous exposure-management platform built around an organizational attack graph. It aggregates and normalizes information about assets, vulnerabilities, controls, identities, and business-critical systems across on-premise, cloud, and hybrid environments, then models plausible attack paths to those assets. The platform's central proposition is prioritization: rather than treating every vulnerability or CVSS score as equally urgent, it attempts to identify exploitable paths and estimate the financial consequences of exposure. Cye describes an Industry Attack Graph for baseline visibility and a deeper Organizational Attack Graph for customer-specific paths. Its current product messaging also includes agentic AI analysis, control validation, auto-simulation, natural-language querying, automated reporting, and AI-risk maturity assessment. These are meaningful capabilities if the underlying asset relationships, exploitability judgments, and loss estimates are accurate and continuously refreshed.
The primary market is enterprise cyber-risk management, especially for regulated or high-risk organizations in financial services, critical infrastructure, healthcare, technology, retail, and complex multi-subsidiary groups. Buyers and users include CISOs, security operations leaders, risk officers, GRC teams, executive leadership, and boards; MSSPs and channel partners can also use the platform in a managed-service model. The commercial need is credible: security teams have more findings than they can remediate, while executives and finance leaders need defensible explanations of why one control or remediation project deserves funding over another. Cye's exposure-to-business-impact framing can support vulnerability remediation, control validation, cyber-risk quantification, maturity benchmarking, board reporting, and security-budget planning. The company's public materials report 500+ organizations supported, more than $20B in exposure quantified, and more than one million attack paths analyzed; these are company-reported indicators rather than independently audited revenue or retention metrics.
Competition is broad and includes cyber-risk quantification specialists, security-rating providers, attack-surface and exposure-management platforms, breach-and-attack simulation vendors, vulnerability-management suites, and consulting firms. Relevant substitutes include BitSight and SecurityScorecard for external ratings, Balbix and RiskLens-style quantitative approaches for risk modeling, XM Cyber and Tenable for exposure and attack-path workflows, and Safe Security for cyber-risk management. Cye's claimed edge is the integration of financially quantified risk, real attack-path prioritization, continuous assessment, automated mitigation workflows, and embedded expert services in one operating model. That combination may improve adoption for organizations that need interpretation and remediation guidance, but it can also create delivery costs and make product differentiation harder to prove as larger security platforms add exposure graphs and AI features. Publicly visible certifications and customer-facing metrics improve enterprise credibility, but diligence should still test independent efficacy, deployment effort, renewal rates, gross margin, and the proportion of value delivered by software versus services.
The national-security relevance is credible but defensive. Attack-path analysis, control validation, mission-impact prioritization, and financial or operational risk quantification can support resilience planning for defense suppliers, critical infrastructure, and government-adjacent enterprises. The same capabilities can help identify high-consequence dependencies, prioritize hardening under constrained budgets, and communicate cyber risk across technical and operational leadership. Cye is not principally an offensive weapons or intelligence platform, and the record should not imply government contracts or classified deployments without evidence. Dual-use value therefore depends on secure handling of highly sensitive asset and identity data, suitability for restricted environments, integration with public-sector control frameworks, and whether the product can operate reliably where telemetry is incomplete or network access is constrained.
Dual-Use Assessment
Cye's core exposure-management technology has substantive defensive dual-use potential: attack-graph analysis, control validation, and impact-based prioritization can support commercial enterprises as well as defense suppliers, critical infrastructure, and other mission-critical operators. The applicability is strongest for resilience and mission assurance, not offensive operations. Diligence should verify data-isolation controls, deployment options for sensitive environments, public-sector security requirements, and whether the platform's loss estimates remain useful when operational and classified context cannot be fully ingested.
Strategic Fit Assessment
Priority signal means this entry may be worth researching within the Claw & Talon thesis. It does not mean investable, suitable, endorsed, available, or likely to produce returns.
Cye is a mature private cybersecurity company with a credible strategic fit for a dual-use security database: its platform links technical exposure to business impact, and its defensive attack-path and control-validation capabilities can support resilience in critical sectors. The 2021 growth investment led by EQT, with participation from 83North, is a stronger financing signal than the prior Series A label, while current public materials indicate a substantial enterprise customer base. This is a strategic-priority signal rather than an investment recommendation. Diligence should focus on recurring software revenue versus services revenue, retention and expansion, model validation against incidents, deployment friction, competitive win rates, sensitive-data governance, and the impact of larger platform vendors entering exposure management.
Strategic Value to U.S.-Israel Alliance
Cye can improve cyber-resilience decision quality by showing which weaknesses create the most exploitable paths to important systems and by expressing potential impact in business or mission terms. That is relevant to critical infrastructure, defense-industrial supply chains, and large enterprises with constrained remediation budgets. Strategic value is conditional on trustworthy telemetry, explainable models, secure multi-tenant operations, and evidence that recommended actions produce measurable risk reduction rather than only better reporting.
Key Technologies
- Organizational and industry attack graphs for asset-to-asset path analysis
- Continuous exposure assessment across on-premise, cloud, and hybrid environments
- Cyber risk quantification that estimates financial impact of potential breaches
- Exploitability- and impact-based remediation prioritization
- Agentic AI analysis, natural-language exposure queries, and automated board reporting
- Control validation, auto-simulation, and cybersecurity maturity benchmarking against NIST CSF 2.0
Use Cases & Applications
- Prioritizing enterprise vulnerability remediation by attack path and business impact
- Quantifying cyber exposure for board, CFO, insurance, and budget discussions
- Continuous threat exposure management across subsidiaries and business units
- Validating whether security controls block high-consequence attack routes
- Third-party and supplier exposure assessment for regulated enterprises
- Mission-assurance and resilience prioritization for critical infrastructure and defense suppliers
- AI-risk maturity and shadow-AI exposure assessment
- Managed exposure-management services delivered by MSSPs and channel partners
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work.
This record lists 6 public references used for company identity, status, positioning, or material-claim review.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- cyesec.com Public source used for profile verification.
- cyesec.com Public source used for profile verification.
- news.cision.com Public source used for profile verification.
- LinkedIn company page Public source used for profile verification.
- 83north.com Public source used for profile verification.
- Official website
- Profile update timestamp Last updated in the Claw & Talon database on Jul 31, 2026.
Investor Lens
What this entry is
Private startup
Why it may matter
Cye may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.
How an independent investor should read this
Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify traction
- Verify cap table/funding
- Verify technical claims
- Verify regulatory/export-control issues
- Verify customer concentration
Main investor questions
- Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
- What customer, revenue, product, and technical evidence supports the company story?
- What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
- Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies Cye's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
- How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
- What would disconfirm the priority signal: weak customer references, thin technical differentiation, poor capital efficiency, or limited allied-market access?
Related sector
See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.
Related companies
Need a diligence readout?
Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.